Bluesky Facebook Reddit Email

Cardiac injury and elevated levels of inflammatory biomarkers in patients with COVID-19

01.19.21 | Compuscript Ltd

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

In a new publication from Cardiovascular Innovations and Applications ; DOI https://doi.org/10.15212/CVIA.2019.1264 , Jing Li, Lijie Sun, Fang Wang, Bing Liu, Hui Li, Guodong Tang, Zhigang Chang, Aihua Liu, Chunyi Fu, You Lv, Jing Gao, and Jing Li, from the Beijing Hospital, Beijing, China, Capital Medical University, Beijing, China and the National Clinical Research Center of Geriatric Disease, Xuanwu Hospital, Beijing, China consider the relationship between cardiac injury and elevated levels of inflammatory biomarkers in patients with severe COVID-19.

Coronavirus disease 2019 (COVID-19) emerged as a global pandemic and public health crisis from December 2019.

This study explores the relationship between cardiac injury and inflammatory biomarkers in patients with severe COVID-19. The authors collected data on patients with a confirmed diagnosis of severe COVID-19 comparing demographics, clinical data, and in-hospital outcomes. The relationship between cardiac injury and inflammatory biomarkers was analyzed.

The authors conclude that high levels of inflammatory biomarkers are associated with higher risk of cardiac injury in patients with severe COVID-19 with IL-2R and comorbidities as predictors of cardiac injury.

###

Citation information: Relation between Cardiac Injury and Elevated Levels with Severe COVID-19 of Inflammatory Biomarkers in Patients, Jing Li, Lijie Sun, Fang Wang, Bing Liu, Hui Li, Guodong Tang, Zhigang Chang, Aihua Liu, Chunyi Fu, You Lv, Jing Gao, and Jing Li, Cardiovasc. Innov. App., 2021, https://doi.org/10.15212/CVIA.2019.1264

Keywords: Inflammatory biomarker; cardiac injury; COVID-19; risk

CVIA is available on the IngentaConnect platform and at Cardiovascular Innovations and Applications . Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. CVIA is indexed in the EMBASE, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Cardiovascular Innovations and Applications

10.15212/CVIA.2019.1264

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
Compuscript Ltd. (2021, January 19). Cardiac injury and elevated levels of inflammatory biomarkers in patients with COVID-19. Brightsurf News. https://www.brightsurf.com/news/19N230J1/cardiac-injury-and-elevated-levels-of-inflammatory-biomarkers-in-patients-with-covid-19.html
MLA:
"Cardiac injury and elevated levels of inflammatory biomarkers in patients with COVID-19." Brightsurf News, Jan. 19 2021, https://www.brightsurf.com/news/19N230J1/cardiac-injury-and-elevated-levels-of-inflammatory-biomarkers-in-patients-with-covid-19.html.